Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myomo (MYO) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Myomo (MYO) over the last 10 years, with Q3 2025 value amounting to $10.0 million.

  • Myomo's Operating Expenses rose 2602.34% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.6 million, marking a year-over-year increase of 5187.33%. This contributed to the annual value of $29.4 million for FY2024, which is 3725.66% up from last year.
  • Per Myomo's latest filing, its Operating Expenses stood at $10.0 million for Q3 2025, which was up 2602.34% from $10.6 million recorded in Q2 2025.
  • Myomo's Operating Expenses' 5-year high stood at $10.6 million during Q2 2025, with a 5-year trough of $4.6 million in Q1 2021.
  • Moreover, its 5-year median value for Operating Expenses was $5.5 million (2023), whereas its average is $6.5 million.
  • Per our database at Business Quant, Myomo's Operating Expenses tumbled by 1666.43% in 2022 and then surged by 6524.13% in 2025.
  • Quarter analysis of 5 years shows Myomo's Operating Expenses stood at $5.8 million in 2021, then dropped by 16.66% to $4.9 million in 2022, then rose by 14.02% to $5.5 million in 2023, then soared by 59.99% to $8.9 million in 2024, then increased by 12.41% to $10.0 million in 2025.
  • Its Operating Expenses was $10.0 million in Q3 2025, compared to $10.6 million in Q2 2025 and $10.1 million in Q1 2025.